Study Completed

Contraception, Heavy Menstrual Bleeding (HMB)

Bayer Identifier:

90647

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2005-004999-21

EU CT Number:

Not Available

Relative BA 1st/4th and 2nd/3rd phase

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

45 - 75 Years

Trial summary

Enrollment Goal

Trial Dates

June 2006 - August 2006

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Natazia/Qlaira (EV/DNG, BAY86-5027)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	Bayer Pharma AG	Berlin, 13353, Germany

Trial design

Open label randomized single dose three way crossover two parallel group study to evaluate the relative bioavailability of the estradiol valerate and or dienogest tablet formulations contained in SH T00658ID versus suspensions, containing the same drugs after oral administration in healthy postmenopausal women

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.